NAV2 and endometrioid stromal sarcoma: Uterine leiomyosarcomas have been shown to overexpress NAV2 when compared to endometrial stromal sarcomas [48], and it has been proposed as a candidate prognostic marker in uterine leiomyosarcoma [49].